Scarica l'app Stockscreener
0.681
6.57%
-0.0479
Dopo l'orario di chiusura:
.71
0.029
+4.26%
Precedente Chiudi:
$0.7289
Aprire:
$0.7445
Volume 24 ore:
584.14K
Relative Volume:
1.74
Capitalizzazione di mercato:
$86.01M
Reddito:
-
Utile/perdita netta:
$-70.78M
Rapporto P/E:
-1.2161
EPS:
-0.56
Flusso di cassa netto:
$-61.27M
1 W Prestazione:
-5.51%
1M Prestazione:
-1.00%
6M Prestazione:
-29.06%
1 anno Prestazione:
-77.30%
Intervallo 1D:
$0.681
$0.7711
Intervallo di 1 settimana:
$0.681
$0.7988
Portata 52W:
$0.62
$3.09
Nautilus Biotechnology Inc Stock (NAUT) Company Profile
Nome
Nautilus Biotechnology Inc
Settore
Industria
Telefono
206-333-2001
Indirizzo
2701 EASTLAKE AVE EAST, SEATTLE
Confronta NAUT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NAUT
Nautilus Biotechnology Inc
|
0.681 | 92.06M | 0 | -70.78M | -61.27M | -0.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Nautilus Biotechnology Inc Stock (NAUT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-05 | Downgrade | Goldman | Neutral → Sell |
| 2024-06-27 | Iniziato | Guggenheim | Buy |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2022-01-06 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-11-02 | Iniziato | Cowen | Outperform |
| 2021-08-04 | Iniziato | Goldman | Neutral |
| 2021-07-13 | Iniziato | Jefferies | Buy |
Mostra tutto
Nautilus Biotechnology Inc Borsa (NAUT) Ultime notizie
Nautilus Biotechnology Inc. stock daily chart insightsMarket Rally & Scalable Portfolio Growth Methods - newser.com
Will Nautilus Biotechnology Inc. see short term momentumShare Buyback & Verified Momentum Stock Ideas - newser.com
What does recent volatility data suggest for Nautilus Biotechnology Inc.2025 AllTime Highs & Technical Analysis for Trade Confirmation - newser.com
How institutional ownership impacts Nautilus Biotechnology Inc. stockQuarterly Risk Review & Safe Capital Growth Stock Tips - newser.com
Published on: 2025-09-19 15:19:07 - khodrobank.com
Nautilus Biotechnology Inc. recovery potential after sell offWeekly Market Summary & Daily Growth Stock Tips - newser.com
Aug PostEarnings: Can Nautilus Biotechnology Inc deliver consistent EPS growth2025 Valuation Update & Daily Stock Momentum Reports - khodrobank.com
How to build a dashboard for Nautilus Biotechnology Inc. stock2025 Fundamental Recap & Reliable Price Breakout Alerts - newser.com
Dip Buying: Is Nautilus Biotechnology Inc. stock a good pick for beginnersEarnings Trend Report & Verified Entry Point Detection - khodrobank.com
How sentiment analysis helps forecast Nautilus Biotechnology Inc.Market Activity Report & Weekly Breakout Stock Alerts - newser.com
Trade Report: Is Nautilus Biotechnology Inc stock good for income investorsJuly 2025 Setups & Weekly Consistent Profit Watchlists - خودرو بانک
Using AI based signals to follow Nautilus Biotechnology Inc.Trade Risk Report & Reliable Entry Point Alerts - newser.com
Is Nautilus Biotechnology Inc. still worth holding after the dip2025 Volatility Report & Fast Entry and Exit Trade Plans - newser.com
Exit strategy if you’re trapped in Nautilus Biotechnology Inc.July 2025 Sentiment & Free Reliable Trade Execution Plans - newser.com
Sectors Review: Will Nautilus Biotechnology Inc stock hit new highs in YEAR2025 Price Targets & Smart Investment Allocation Tips - khodrobank.com
Gains Recap: Whats the MACD signal for Nautilus Biotechnology IncJuly 2025 Macro Moves & Expert Verified Stock Movement Alerts - khodrobank.com
Growth Value: Is RFPRE gaining market shareTrade Volume Report & AI Forecast for Swing Trade Picks - خودرو بانک
Published on: 2025-09-17 01:24:05 - khodrobank.com
Nautilus Biotechnology at Q3 Investor Summit: Proteomics Push By Investing.com - Investing.com India
Shorts Report: Will PRTC face regulatory challengesJuly 2025 News Drivers & Growth Focused Entry Point Reports - خودرو بانک
Favourable Signals For Nautilus Biotechnology: Numerous Insiders Acquired Stock - simplywall.st
Market Moves: Should I hold or sell Nautilus Biotechnology Inc nowEarnings Trend Report & Risk Managed Investment Strategies - khodrobank.com
Will Nautilus Biotechnology Inc stock hit new highs in YEARWeekly Market Outlook & Verified Short-Term Plans - خودرو بانک
How to monitor Nautilus Biotechnology Inc. with trend dashboardsCEO Change & Smart Swing Trading Alerts - newser.com
Breakouts Watch: Can Nautilus Biotechnology Inc deliver consistent EPS growthJuly 2025 Market Mood & Reliable Intraday Trade Plans - khodrobank.com
Nautilus Biotechnology (NASDAQ:NAUT) CEO Sujal M. Patel Acquires 83,500 Shares - MarketBeat
Insider Buying: Nautilus Biotechnology (NASDAQ:NAUT) CEO Purchases 116,500 Shares of Stock - MarketBeat
Nautilus Biotechnology to Participate in Upcoming September Investor Conferences - Investing News Network
What the charts say about Nautilus Biotechnology Inc. todayQuarterly Trade Summary & Verified Entry Point Signals - Newser
Can momentum traders help lift Nautilus Biotechnology Inc.Insider Buying & Stock Portfolio Risk Control - Newser
Nautilus Biotechnology Inc Azioni (NAUT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.43%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):